comparemela.com

Latest Breaking News On - Tandem diabetes care inc - Page 1 : comparemela.com

Dick Allen Sells 5,000 Shares of Tandem Diabetes Care, Inc (NASDAQ:TNDM) Stock

Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) Director Dick Allen sold 5,000 shares of Tandem Diabetes Care stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $51.68, for a total transaction of $258,400.00. Following the sale, the director now directly owns 24,396 shares […]

Q2 2024 EPS Estimates for Tandem Diabetes Care, Inc Reduced by Analyst (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2024 earnings estimates for Tandem Diabetes Care in a research note issued to investors on Tuesday, May 28th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of ($0.53) per share for […]

Tandem Diabetes Care (NASDAQ:TNDM) Now Covered by Redburn Atlantic

Stock analysts at Redburn Atlantic began coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) in a report issued on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $60.00 price target on the medical device company’s stock. Redburn Atlantic’s target price suggests a potential upside of 17.12% from the […]

Analysts Set Tandem Diabetes Care, Inc (NASDAQ:TNDM) Price Target at $43 80

Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average […]

Tandem Diabetes Care, Inc (NASDAQ:TNDM) Given Average Rating of Moderate Buy by Brokerages

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have earned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.